CARA - Cara Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - CARA (1346830)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
26 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P1-3-1-19+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-12-03
CARAMenzaghi Frederique Ph.D.SVP-Research, DevelopmentS - Sale$18.36-3,000139,000-2%-$55,080
2018-12-03
CARAChalmers Derek TPres, CEOS - Sale$18.17-20,000971,392-2%-$363,400
D
2018-11-15
CARAMohindru ManiCFO, Chief Strategy OfficerS - Sale+OE$18.50-16,0420-100%-$296,777
D
2018-11-01
CARAMenzaghi Frederique Ph.D.SVP-Research, DevelopmentS - Sale+OE$18.77-3,000142,000-2%-$56,310
2018-11-01
CARAChalmers Derek TPres, CEOS - Sale$18.78-20,000991,392-2%-$375,600
2018-10-17
CARAStauffer Joseph WilliamChief Medical OfficerS - Sale$20.13-11,4422,000-85%-$230,347
D
2018-10-17
CARAMohindru ManiCFO, Chief Strategy OfficerS - Sale+OE$20.19-16,0420-100%-$323,888
2018-10-01
CARAMenzaghi Frederique Ph.D.SVP-Research, DevelopmentS - Sale$23.99-3,00095,000-3%-$71,970
2018-10-01
CARAChalmers Derek TPres, CEOS - Sale$23.79-20,0001,011,392-2%-$475,800
2018-09-04
CARAChalmers Derek TPres, CEOS - Sale$19.71-20,0001,031,392-2%-$394,200
2018-09-04
CARAMenzaghi Frederique Ph.D.SVP-Research, DevelopmentS - Sale$19.81-3,00098,000-3%-$59,430
2018-08-20
CARAMenzaghi Frederique Ph.D.SVP-Research, DevelopmentS - Sale$18.89-3,000101,000-3%-$56,670
2018-07-10
CARAChalmers Derek TPres, CEOS - Sale$20.64-20,0001,051,392-2%-$412,800
2018-07-02
CARAMenzaghi Frederique Ph.D.SVP-Research, DevelopmentS - Sale$19.00-3,000104,000-3%-$57,000
2018-06-01
CARAMenzaghi Frederique Ph.D.SVP-Research, DevelopmentS - Sale$15.49-3,000107,000-3%-$46,470
2018-05-23
CARAMenzaghi Frederique Ph.D.SVP-Research, DevelopmentS - Sale$15.19-9,000110,000-8%-$136,710
2018-02-16
CARAChalmers Derek TPres, CEOS - Sale$15.00-5,4001,071,392-1%-$81,000
2018-02-15
CARAMenzaghi Frederique Ph.D.SVP-Research, DevelopmentS - Sale$15.02-3,000119,000-2%-$45,060
2018-01-24
CARAMenzaghi Frederique Ph.D.SVP-Research, DevelopmentS - Sale$15.00-15,000122,000-11%-$225,000
D
2018-01-24
CARAChalmers Derek TPres, CEOS - Sale+OE$15.00-12,5001,076,792-1%-$187,500
D
2017-11-01
CARAChalmers Derek TPres, CEOS - Sale+OE$12.66-16,0001,086,292-1%-$202,560
2017-08-04
CARAMenzaghi Frederique Ph.D.VP-Research, DevelopmentS - Sale$15.00-3,000117,000-3%-$45,000
D
2017-07-14
CARAChalmers Derek TPres, CEOS - Sale+OE$15.05-25,0001,082,292-2%-$376,250
2017-07-14
CARAMenzaghi Frederique Ph.D.VP-Research, DevelopmentS - Sale$15.00-3,000120,000-2%-$45,000
2017-06-29
CARASlagel DeanDirS - Sale$25.87-250,0001,064,338-19%-$6,468,564
2017-03-31
CARARho Ventures VI LP10%P - Purchase$18.19+500,0003,568,057+16%+$9,095,700-3-1-19
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top